Moderna (NASDAQ: MRNA) stock skyrocketed last year, moving over 434% on global demand for coronavirus vaccines. The question now is whether it can continue to rally higher, with or without COVID-19. The short answer is "no". But one biotech stock very well might. We'll share that one with you right here... Read more... Tags: stocks to sell The post Is It Too Late to Buy Moderna Stock? appeared first on Money Morning - We Make Investing Profitable .